Plasmodium vivax: Prevalence of mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium vivax clinical isolates from Pakistan

Experimental Parasitology

Volumn 127, Issue 1, 2011, Pages 167-172

  Zakeri, Sedigheh ^a   Afsharpad, Mandana ^a   Ghasemi, Faezeh ^a   Raeisi, Ahmad ^b   Kakar, Qutbuddin ^c   Atta, Hoda ^d   Djadid, Navid Dinparast ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

^b MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

^c Roll Back Malaria   (Pakistan)

^d WHO/EMRO   (Egypt)

Author keywords

Malaria; Mutations; Plasmodium vivax; Pvdhfr; Pvdhps; Sulfadoxine pyrimethamine (SP)

Indexed keywords

AMINO ACID; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; GENOMIC DNA; PYRIMETHAMINE PLUS SULFADOXINE;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DHFR GENE; DHPS GENE; DRUG TOLERANCE; ENDEMIC DISEASE; FEMALE; GENE; GIEMSA STAIN; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTANT; MUTATION RATE; MUTATIONAL ANALYSIS; NONHUMAN; PAKISTAN; PHYSICAL RESISTANCE; PLASMODIUM VIVAX; PLASMODIUM VIVAX MALARIA; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM; WILD TYPE;

ADOLESCENT; ADULT; ANTIMALARIALS; CHILD; CHILD, PRESCHOOL; DIHYDROPTEROATE SYNTHASE; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; HAPLOTYPES; HUMANS; INFANT; MALARIA, VIVAX; MALE; MUTATION; PAKISTAN; PLASMODIUM VIVAX; PREVALENCE; PYRIMETHAMINE; SULFADOXINE; TETRAHYDROFOLATE DEHYDROGENASE;

PLASMODIUM VIVAX;

EID: 78650579363     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2010.07.011     Document Type: Article

References (40)

1. Auliff A., Wilson D.W., Russell B., Gao Q., Chen N., Anh le N., Maguire J., Bell D., O'Neil M.T., Cheng Q. Amino acid mutations in Plasmodium vivax DHFR and DHPS from several geographical regions and susceptibility to antifolate drugs. The American Journal of Tropical Medicine and Hygiene 2006, 75:617-621.
2. Baird J.K., Basri H., Jones T.R., Purnomo, Bangs M.J., Ritonga A. Resistance to antimalarials by Plasmodium falciparum in Arso PIR, Irian Jaya, Indonesia. The American Journal of Tropical Medicine and Hygiene 1991, 44:640-644.
3. Baird J.K., Sustriayu Nalim M.F., Basri H., Masbar S., Leksana B., Tjitra E. Survey of resistance to chloroquine by Plasmodium vivax in Indonesia. Transactions of the Royal Society of Tropical Medicine and Hygiene 1996, 90:409-411.
4. Barat L.M., Bloland P.B. Drug resistance among malaria and other parasites. Infectious Disease Clinics of North America 1997, 11:969-987.
5. Barcus M.J., Basri H., Picarima H., Manyakori C., Sekartuti, Elyazar I, Bangs M.J., Maguire J.D., Baird J.K. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. The American Journal of Tropical Medicine and Hygiene 2007, 77:984-991.
6. Barnadas C., Tichit M., Bouchier C., Ratsimbasoa A., Randrianasolo L., Raherinjafy R., Jahevitra M., Picot S., Ménard D. Plasmodium vivax dhfr and dhps mutations in isolates from Madagascar and therapeutic response to sulphadoxine-pyrimethamine. Malaria Journal 2008, 7:35.
7. Bonilla J.A., Validum L., Cummings R., Palmer C.J. Genetic diversity of Plasmodium vivax pvcsp and pvmsp1 in Guyana, South America. The American Journal of Tropical Medicine and Hygiene 2006, 75:830-835.
8. de Pécoulas P.E., Tahar R., Ouatas T., Mazabraud A., Basco L.K. Sequence variations in the Plasmodium vivax dihydrofolate reductase-thymidylate synthase gene and their relationship with pyrimethamine resistance. Molecular and Biochemical Parasitology 1998, 92:265-273.
9. Foote S.J., Cowman A.F. The mode of action and the mechanism of resistance to antimalarial drugs. Acta Tropica 1994, 56:157-171.
10. Garg M., Gopinathan N., Bodhe P., Kshirsagar N.A. Vivax malaria resistant to chloroquine: case reports from Bombay. Transactions of the Royal Society of Tropical Medicine and Hygiene 1995, 89:656-657.
11. Gregson A., Plowe C.V. Mechanisms of resistance of malaria parasites to antifolates. Pharmacological Reviews 2005, 57:117-145.
12. Hastings M.D., Porter K.M., Maguire J.D., Susanti I., Kania W., Bangs M.J., Sibley C.H., Baird J.K. Dihydrofolate reductase mutations in Plasmodium vivax from Indonesia and therapeutic response to sulfadoxine plus pyrimethamine. Journal of Infectious Diseases 2004, 189:744-750.
13. Hastings M.D., Sibley C.H. Pyrimethamine and WR99210 exert opposing selection on dihydrofolate reductase from Plasmodium vivax. Proceedings of the National Academy of Sciences of the United States of America 2002, 99:13137-13141.
14. Hawkins V.N., Joshi H., Rungsihirunrat K., Na-Bangchang K., Sibley C.H. Antifolates can have a role in the treatment of Plasmodium vivax. Trends in Parasitology 2007, 23:213-222.
15. Imwong M., Pukrittayakamee S., Cheng Q., Moore C., Looareesuwan S., Snounou G., White N.J., Day N.P. Limited polymorphism in the dihydropteroate synthetase gene (dhps) of Plasmodium vivax isolates from Thailand. Antimicrobial Agents and Chemotherapy 2005, 49:4393-4395.
16. Imwong M., Pukrittakayamee S., Looareesuwan S., Pasvol G., Poirreiz J., White N.J., Snounou G. Association of genetic mutations in Plasmodium vivax dhfr with resistance to sulfadoxine-pyrimethamine: geographical and clinical correlates. Antimicrobial Agents and Chemotherapy 2001, 45:3122-3127.
17. Imwong M., Pukrittayakamee S., Rénia L., Letourneur F., Charlieu J.P., Leartsakulpanich U., Looareesuwan S., White N.J., Snounou G. Novel point mutations in the dihydrofolate reductase gene of Plasmodium vivax: evidence for sequential selection by drug pressure. Antimicrobial Agents and Chemotherapy 2003, 47:1514-1521.
18. Kaur S., Prajapati S.K., Kalyanaraman K., Mohmmed A., Joshi H., Chauhan V.S. Plasmodium vivax dihydrofolate reductase point mutations from the Indian subcontinent. Acta Tropica 2006, 97:174-180.
19. Khatoon L., Baliraine F.N., Bonizzoni M., Malik S.A., Yan G. Prevalence of antimalarial drug resistance mutations in Plasmodium vivax and P. falciparum from a malaria-endemic area of Pakistan. The American Journal of Tropical Medicine and Hygiene 2009, 81:525-528.
20. Korsinczky M., Fischer K., Chen N., Baker J., Rieckmann K., Cheng Q. Sulfadoxine resistance in Plasmodium vivax is associated with a specific amino acid in dihydropteroate synthase at the putative sulfadoxine-binding site. Antimicrobial Agents and Chemotherapy 2004, 48:2214-2222.
21. Kurcer M.A., Simsek Z., Kurcer Z. The decreasing efficacy of chloroquine in the treatment of Plasmodium vivax malaria, in Sanliurfa, south-eastern Turkey. Annals of Tropical Medicine and Parasitology 2006, 100:109-113.
22. Mendis K., Sina B.J., Marchesini P., Carter R. The neglected burden of Plasmodium vivax malaria. The American Journal of Tropical Medicine and Hygiene 2001, 64:97-106.
23. Murphy G.S., Basri H., Purnomo, Andersen E.M., Bangs M.J., Mount D.L., Gorden J., Lal A.A., Purwokusumo A.R., Harjosuwarno S., et al. Vivax malaria resistant to treatment and prophylaxis with chloroquine. Lancet 1993, 341:96-100.
24. Nateghpour M., Sayedzadeh S.A., Edrissian Gh.H., Raeisi A., Jahantigh A., Motevalli-Haghi A., Mohseni Gh., Rahimi A. Evaluation of sensitivity of Plasmodium vivax to chloroquine. Iranian Journal of Public Health 2007, 36:60-63.
25. Nomura T., Carlton J.M., Baird J.K., Del Portillo H.A., Fryauff D.J., Rathore D., Fidock D.A., Su X., Collins W.E., McCutchan T.F., Wootton J.C., Wellems T.E. Evidence for different mechanisms of chloroquine resistance in 2 Plasmodium species that cause human malaria. The Journal of Infectious Diseases 2001, 183:1653-1661.
26. Phan G.T., de Vries P.J., Tran B.Q., Le H.Q., Nguyen N.V., Nguyen T.V., Heisterkamp S.H., Kager P.A. Artemisinin or chloroquine for blood stage Plasmodium vivax malaria in Vietnam. Tropical Medicine & International Health 2002, 7:858-864.
27. Phillips E.J., Keystone J.S., Kain K.C. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Clinical Infectious Diseases 1996, 23:1171-1173.
28. Plowe C.V., Cortese J.F., Djimde A., Nwanyanwu O.C., Watkins W.M., Winstanley P.A., Estrada-Franco J.G., Mollinedo R.E., Avila J.C., Cespedes J.L., Carter D., Doumbo O.K. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. Journal of Infectious Diseases 1997, 176:1590-1596.
29. Rieckmann K.H., Davis D.R., Hutton D.C. Plasmodium vivax resistance to chloroquine?. Lancet 1989, 2:1183-1184.
30. Snounou G., Viriyakosol S., Jarra W., Thaithong S., Brown K.N. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Molecular and Biochemical Parasitology 1993, 58:283-292.
31. Snounou G., Viriyakosol S., Zhu X.P., Jarra W., Pinheiro L., do Rosario V.E., Thaithong S., Brown K.N. High sensitivity of detection of human malaria parasites by the use of nested polymerase chain reaction. Molecular and Biochemical Parasitology 1993, 61:315-320.
32. Soto J., Toledo J., Gutierrez P., Luzz M., Llinas N., Cedeño N., Dunne M., Berman J. Plasmodium vivax clinically resistant to chloroquine in Colombia. The American Journal of Tropical Medicine and Hygiene 2001, 65:90-93.
33. Than M., Kyaw M.P., Soe A.Y., Gyi K.K., Sabai M., Oo M. Development of resistance to chloroquine by Plasmodium vivax in Myanmar. Transactions of the Royal Society of Tropical Medicine and Hygiene 1995, 89:307-308.
34. Tjitra E., Anstey N.M., Sugiarto P., Warikar N., Kenangalem E., Karyana M., Lampah D.A., Price R.N. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Medicine 2008, 5:e128.
35. Tjitra E., Baker J., Suprianto S., Cheng Q., Anstey N.M. Therapeutic efficacies of artesunate-sulfadoxine-pyrimethamine and chloroquine-sulfadoxine-pyrimethamine in vivax malaria pilot studies: relationship to Plasmodium vivax dhfr mutations. Antimicrobial Agents and Chemotherapy 2002, 46:3947-3953.
36. Triglia T., Menting J.G., Wilson C., Cowman A.F. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proceedings of the National Academy of Sciences of the United States of America 1997, 94:13944-13949.
37. Van den Abbeele K., Van den Enden E., Van den Ende J. Combined chloroquine and primaquine resistant Plasmodium vivax malaria in a patient returning from India. Annales de la Société Belge de Médecine Tropicale 1995, 75:73-74.
38. World Health Organization (WHO). Regional office for the Eastern Mediterranean. 2008. .
39. Zakeri S., Kakar Q., Ghasemi F., Raeisi A., Butt W., Safi N., Afsharpad M., Memon M.S., Gholizadeh S., Salehi M., Atta H., Zamani Gh., Djadid N.D. Detection of high prevalence of mixed Plasmodium falciparum and P. vivax infections by nested-PCR in Pakistan and Iran but not in Afghanistan. The Indian Journal of Medical Research 2010, 132:23-27.
40. Zakeri S., Motmaen S.R., Afsharpad M., Djadid N.D. Molecular characterization of antifolates resistance-associated genes (dhfr and dhps) in Plasmodium vivax isolates from the Middle East. Malaria Journal 2009, 8:20.